LXEO – lexeo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
How decentralisation can fill the gaps in Alzheimer's research [Yahoo! Finance]
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target raised by analysts at HC Wainwright from $21.00 to $23.00. They now have a "buy" rating on the stock.
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target raised by analysts at Chardan Capital from $23.00 to $25.00. They now have a "buy" rating on the stock.
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Leerink Partners from $20.00 to $19.00. They now have an "outperform" rating on the stock.
Lexeo Therapeutics GAAP EPS of -$0.89 misses by $0.24 [Seeking Alpha]
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: Lundbeckfond Invest A/S
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: Longitude Capital Partners IV, LLC
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
Form 4 Lexeo Therapeutics, Inc. For: Nov 11 Filed by: Tanguler Tolga
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.